Biomet Provides Preliminary Third Quarter Guidance at the American Academy of Orthopaedic Surgeons Analyst Meeting.

Business Editors/Health/Medical Writers

WARSAW, Ind.--(BUSINESS WIRE)--March 12, 2004

Biomet, Inc. (Nasdaq:BMET) announced at its Analyst Meeting during the American Academy of Orthopaedic Surgeons (AAOS) that it expects to exceed consensus sales estimates of $402 million by approximately $8 million and consensus earnings per share of $0.32 by $0.02 when Biomet reports its fiscal year 2004 third quarter earnings on March 17, 2004. The webcast of the Analyst Meeting, which was previously announced by Biomet, is accessible through Biomet's website at www.biomet.com (Investor Section) or at www.streetevents.com.

The conference call discussing the third quarter results will be on Wednesday, March 17, 2004, at 10:00 a.m. Eastern Time. Individuals wishing to participate in the conference call may dial [phone]. The confirmation number for the call is 229430.

Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy, including reconstructive and fixation devices, electrical bone growth stimulators, orthopedic support devices, operating room supplies, general surgical instruments, arthroscopy products, spinal implants, bone cements and accessories, bone substitute materials, craniomaxillofacial implants and dental reconstructive implants and associated instrumentation. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in more than 100 countries.

For further information contact Greg W. Sasso, Vice President, Corporate Development and Communications at [phone] or Barbara Goslee, Manager, Corporate Communications at [phone].

This press release contains certain statements that are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. Although the Company believes that the assumptions, on which the forward-looking statements contained herein are based, are reasonable, any of those assumptions could prove to be inaccurate given the inherent uncertainties as to the occurrence or non-occurrence of future events. There can be no assurance that the forward-looking statements contained in this press release will prove to be accurate. The inclusion of a forward-looking statement herein should not be regarded as a representation by the Company that the Company's objectives will be achieved.

All trademarks are owned by Biomet, Inc., or one of its subsidiaries.

All of Biomet's financial information may be obtained on our website at www.biomet.com or you may contact us by e-mail at [e-mail].